Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JEFFREY A DAMBROSIO

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical

NPI
1457553927
CMS profile
11075205
Location
CARTERSVILLE, GA

General Payments · PY2021–2024

$862.30

  • Reported across 43 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$321.34

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $321.34 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $188.92 10
GlaxoSmithKline, LLC. $50.12 2
Hikma Pharmaceuticals USA $34.95 2
OptiNose US, Inc. $27.36 1
Kaleo, Inc. $19.99 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $176.78 9
PY2022 $252.04 12
PY2023 $112.14 6
PY2024 $321.34 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
GENZYME CORPORATION $27.26 01/12/2024 Food and Beverage Undisputed 01/23/2026 1139583868 CMS
GENZYME CORPORATION $44.24 01/17/2024 Food and Beverage Undisputed 01/23/2026 1139584048 CMS
GENZYME CORPORATION $19.96 01/19/2024 Food and Beverage Undisputed 01/23/2026 1139583876 CMS
GENZYME CORPORATION $21.16 03/01/2024 Food and Beverage Undisputed 01/23/2026 1139584064 CMS
GENZYME CORPORATION $8.83 05/23/2024 Food and Beverage Undisputed 01/23/2026 1139584090 CMS
GENZYME CORPORATION $7.48 07/25/2024 Food and Beverage Undisputed 01/23/2026 1139584122 CMS
GENZYME CORPORATION $4.18 08/21/2024 Food and Beverage Undisputed 01/23/2026 1139584116 CMS
GENZYME CORPORATION $29.51 10/04/2024 Food and Beverage Undisputed 01/23/2026 1139584130 CMS
GENZYME CORPORATION $2.04 10/16/2024 Food and Beverage Undisputed 01/23/2026 1139584132 CMS
GENZYME CORPORATION $24.26 11/22/2024 Food and Beverage Undisputed 01/23/2026 1139584164 CMS
GlaxoSmithKline, LLC. $24.00 05/29/2024 Food and Beverage Undisputed 01/23/2026 1116737054 CMS
GlaxoSmithKline, LLC. $26.12 11/18/2024 Food and Beverage Undisputed 01/23/2026 1116507533 CMS
Hikma Pharmaceuticals USA $21.09 05/01/2024 Food and Beverage Undisputed 01/23/2026 1127507727 CMS
Hikma Pharmaceuticals USA $13.86 06/12/2024 Food and Beverage Undisputed 01/23/2026 1127507733 CMS
kaleo, Inc. $19.99 02/14/2024 Food and Beverage Undisputed 01/23/2026 1126632822 CMS
Optinose US, Inc. $27.36 06/20/2024 Food and Beverage Undisputed 01/23/2026 1142181662 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.